Dermatologic fungal neglected tropical diseases-Part II. Management and morbidity
- PMID: 38851491
- DOI: 10.1016/j.jaad.2024.03.057
Dermatologic fungal neglected tropical diseases-Part II. Management and morbidity
Abstract
In this part 2 of a 2-part continuing medical education series, the management, outcomes, and morbidities for fungal skin neglected tropical diseases (NTDs), including eumycetoma, chromoblastomycosis, paracoccidioidomycosis, sporotrichosis, emergomycosis, talaromycosis, and lobomycosis are reviewed. While fungal skin NTDs are associated with poverty in resource-limited settings, they are more often associated with immunosuppression and global migration in the United States. These infections have a high morbidity burden, including disfigurement, physical disability, coinfection, malignant transformation, mental health issues, and financial impact. For most fungal skin NTDs, management is difficult and associated with low cure rates. Dermatologists play a central role in initiating appropriate treatment early in disease course in order to improve patient outcomes.
Keywords: chromoblastomycosis; emergomycosis; endemic mycoses; eumycetoma; fungal infections; implantation mycoses; lobomycosis; neglected tropical diseases; outcomes; paracoccidioidomycosis; sporotrichosis; systemic mycoses; talaromycosis; therapeutics.
Copyright © 2024 American Academy of Dermatology, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest Dr Lipner has served as a consultant for Ortho-Dermatologics, Eli Lilly, BelleTorus Corporation, and Moberg Pharmaceuticals. Author Curtis and Drs Ritter, Smith, Gold, Rosen, and Santos have no conflicts of interest to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
